A transcription activator-like effector induction system mediated by proteolysis

Simple and predictable trans-acting regulatory tools are needed in the fields of synthetic biology and metabolic engineering to build complex genetic circuits and optimize the levels of native and heterologous gene products. Transcription activator-like effectors (TALEs) are bacterial virulence factors that have recently gained traction in biotechnology applications due to their customizable DNA binding specificity. In this work we expand the versatility of these transcription factors to create an inducible TALE system by inserting tobacco-etch virus (TEV) protease recognition sites into the TALE backbone. The resulting engineered TALEs maintain transcriptional repression of their target genes in Escherichia coli, but are degraded following the induction of the TEV protease, thereby promoting expression of the previously repressed target gene of interest. This TALE-TEV technology enables both repression and induction of plasmid or chromosomal target genes in a manner analogous to traditional repressor proteins but with the added flexibility of being operator agnostic.

[1]  Meghdad Hajimorad,et al.  BglBrick vectors and datasheets: A synthetic biology platform for gene expression , 2011, Journal of biological engineering.

[2]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[3]  Michel M Maharbiz,et al.  A genetic bistable switch utilizing nonlinear protein degradation , 2012, Journal of biological engineering.

[4]  Huimin Zhao,et al.  Direct observation of TALE protein dynamics reveals a two-state search mechanism , 2015, Nature Communications.

[5]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[6]  J. Doudna,et al.  Large-scale purification of a stable form of recombinant tobacco etch virus protease. , 2001, BioTechniques.

[7]  Philip Bradley,et al.  The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target , 2012, Science.

[8]  Chad W. Euler,et al.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials , 2014, Nature Biotechnology.

[9]  Christopher A. Voigt,et al.  Principles of genetic circuit design , 2014, Nature Methods.

[10]  J. Collins,et al.  Tunable protein degradation in bacteria , 2014, Nature Biotechnology.

[11]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[12]  J. Chai,et al.  Crystal structure of a TALE protein reveals an extended N-terminal DNA binding region , 2012, Cell Research.

[13]  E. Work,et al.  Diaminopimelic Acid and Lysine: Diaminopimelic Acid Decarboxylase , 1952, Nature.

[14]  Yusuke Miyanari,et al.  Live visualization of chromatin dynamics with fluorescent TALEs , 2013, Nature Structural &Molecular Biology.

[15]  Randall J. Platt,et al.  Optical Control of Mammalian Endogenous Transcription and Epigenetic States , 2013, Nature.

[16]  Carlos F. Barbas,et al.  Regulation of Endogenous Human Gene Expression by Ligand-Inducible TALE Transcription Factors , 2013, ACS synthetic biology.

[17]  T. Terwilliger,et al.  Engineering and characterization of a superfolder green fluorescent protein , 2006, Nature Biotechnology.

[18]  W. Reznikoff,et al.  Overlapping divergent promoters control expression of Tn10 tetracycline resistance. , 1983, Gene.

[19]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[20]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[21]  Álvaro L. Pérez-Quintero,et al.  An Improved Method for TAL Effectors DNA-Binding Sites Prediction Reveals Functional Convergence in TAL Repertoires of Xanthomonas oryzae Strains , 2013, PloS one.

[22]  A. Wlodawer,et al.  Structural Basis for the Substrate Specificity of Tobacco Etch Virus Protease* , 2002, The Journal of Biological Chemistry.

[23]  P. Martineau,et al.  Expression of single-chain Fv fragments in E. coli cytoplasm. , 2009, Methods in molecular biology.

[24]  Anne M. Stringer,et al.  FRUIT, a Scar-Free System for Targeted Chromosomal Mutagenesis, Epitope Tagging, and Promoter Replacement in Escherichia coli and Salmonella enterica , 2012, PloS one.

[25]  Mads Kaern,et al.  The engineering of gene regulatory networks. , 2003, Annual review of biomedical engineering.

[26]  R. Gill,et al.  Broad host range vectors for stable genomic library construction , 2006, Biotechnology and bioengineering.

[27]  Ryan R. Richardson,et al.  Two- and three-input TALE-based AND logic computation in embryonic stem cells , 2013, Nucleic acids research.

[28]  Pamela A. Silver,et al.  Engineering synthetic TAL effectors with orthogonal target sites , 2012, Nucleic acids research.

[29]  Steven E. Lindow,et al.  Predictive and Interpretive Simulation of Green Fluorescent Protein Expression in Reporter Bacteria , 2001, Journal of bacteriology.

[30]  T. Lahaye,et al.  From dead leaf, to new life: TAL effectors as tools for synthetic biology. , 2014, The Plant journal : for cell and molecular biology.

[31]  Farshid Guilak,et al.  Synergistic and tunable human gene activation by combinations of synthetic transcription factors , 2013, Nature Methods.

[32]  Jens Boch,et al.  TAL effector RVD specificities and efficiencies , 2012, Nature Biotechnology.

[33]  Moon-Soo Kim,et al.  Quantitative analysis of TALE–DNA interactions suggests polarity effects , 2013, Nucleic acids research.

[34]  J. Park,et al.  Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs , 2013, Nature Biotechnology.

[35]  L. Bleris,et al.  Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression , 2012, Scientific Reports.

[36]  D. Court,et al.  High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  David Baker,et al.  megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering , 2013, Nucleic acids research.

[38]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[40]  Huimin Zhao,et al.  Transcription activator‐like effector nucleases (TALENs): A highly efficient and versatile tool for genome editing , 2013, Biotechnology and bioengineering.

[41]  Brian F Pfleger,et al.  Application of TALEs, CRISPR/Cas and sRNAs as trans-acting regulators in prokaryotes. , 2014, Current opinion in biotechnology.

[42]  Christopher A. Voigt,et al.  Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks , 2014, Molecular systems biology.

[43]  Santiago Garcia-Vallvé,et al.  Working toward a new NIOSH. , 1996, Nucleic Acids Res..

[44]  Luke A. Gilbert,et al.  Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds , 2015, Cell.

[45]  Prashant Mali,et al.  Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing , 2013, Nature Methods.

[46]  Jack A. M. Leunissen,et al.  Turning CFCs into salt. , 1996, Nucleic Acids Res..

[47]  Timothy K Lu,et al.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases , 2014, Nature Biotechnology.

[48]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[49]  Brian F Pfleger,et al.  Artificial repressors for controlling gene expression in bacteria. , 2013, Chemical communications.

[50]  Simone Hahn,et al.  A Bacterial Effector Acts as a Plant Transcription Factor and Induces a Cell Size Regulator , 2007, Science.

[51]  Wei Zhang,et al.  Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System , 2014, Cell.

[52]  D. E. Anderson,et al.  Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. , 2001, Protein engineering.